natgillin/translations-raw huggingface dataset:
The work programme does not detail the estimated human and financial resources necessary to implement the planned actions. 
V delovnem programu ni navedena podrobna ocena kadrovskih in finančnih virov, potrebnih za izvajanje načrtovanih dejavnosti.
In order to ensure full activity-based management, allowing continuous improvement of resource allocation and performance analysis, the Centre should establish measurable objectives with relevant indicators, allocate its resources based on estimated project needs and promote the achieving of results. 
Da se v celoti zagotovi upravljanje na podlagi dejavnosti, ki omogoča stalno izboljševanje dodeljevanja virov in analizo uspešnosti, bi Center moral določiti merljive cilje z ustreznimi kazalniki, svoje vire dodeljevati na podlagi ocenjenih potreb projektov in spodbujati doseganje rezultatov.
In the Court’s opinion, the Centre’s annual accounts (11) present fairly, in all material respects, its financial position as of 31 December 2008 and the results of its operations and its cash flows for the year then ended, in accordance with the provisions of its Financial Regulation. 
Po mnenju Sodišča letni računovodski izkazi Centra (11) v vseh pomembnih vidikih pošteno predstavljajo njegovo finančno stanje na dan 31. decembra 2008 ter rezultate njegovega poslovanja in denarne tokove za leto, ki se je takrat končalo, v skladu z določbami njegove finančne uredbe.
In the Court’s opinion, the transactions underlying the Centre’s annual accounts for the financial year ended 31 December 2008 are, in all material respects, legal and regular. 
Po mnenju Sodišča so transakcije, povezane z letnimi računovodskimi izkazi Centra, za proračunsko leto, ki se je končalo 31. decembra 2008, v vseh pomembnih vidikih zakonite in pravilne.
For the Court of Auditors Vítor Manuel da SILVA CALDEIRA President (11) The Final Annual Accounts were drawn up on 17 June 2009 and received by the Court on 6 July 2009. 
Za Računsko sodišče Vítor Manuel da SILVA CALDEIRA Predsednik (11) Končni letni računovodski izkazi so bili pripravljeni 17. junija 2009, Sodišče pa jih je prejelo 6. julija 2009.
The Final Annual Accounts, consolidated with those of the Commission are published in the Official Journal of the European Union by 15 November of the following year. 
Končni letni računo­ vodski izkazi, konsolidirani z izkazi Komisije so objavljeni v Uradnem listu Evropske unije najpozneje 15. novembra naslednjega leta.
These can be found on the following website http://eca.europa.eu or http://www.emcdda.europa.eu/html.cfm/ index81990EN.html 
Na voljo so na spletnih straneh http://eca.europa.eu ali http:// www.emcdda.europa.eu/html.cfm/index81990EN.html
EN 15.12.2009 OfficialJournaloftheEuropeanUnion C304/151 Areas of Community competence deriving from the Treaty The Centre’s powers as defined in Regulation (EC) No 1920/2006 of the European Parliament and of the Council of 12 December 2006 Governance Resources available to the Centre in 2008 (Data for 2007) Products and services supplied in 2008 The Community complements the Member States’ actions in reducing drugs-related health damage, including information and prevention. 
1920/2006 Evropskega parlamenta in Sveta z dne 12. decembra 2006 Vodenje Viri, ki so bili Centru na voljo v letu 2008 (podatki za leto 2007) Proizvodi in storitve, zagotovljeni v letu 2008 Skupnost dopol­ njuje ukrepe držav članic za zmanjše­ vanje škode za zdravje zaradi uživanja drog, vključno z obvešča­ njem in preprečeva­ njem.
Objectives Tasks 1 — The Management Board Budget Network (Article 152 of the Treaty) The Monitoring Centre should focus on the following priority areas: — To disseminate data. 
Cilji Naloge 1 – Upravni odbor Proračun 15,1 milijona EUR (14,4 mili­ Mreža (Člen 152 Pogodbe) Center za spremljanje bi se moral osredotočiti na naslednja predno­ stna področja: — Širjenje podatkov.
Number of posts in estab­ lishment plan: 82 (82) To provide the European Union and its Member States with factual, objective, reliable and comparable information at Community level concerning drugs, drug addiction and their consequences. — To collect and analyse data. 
Zagotavljati Uniji in državam članicam na ravni Skupnosti dejanske, objektivne, zanesljive in primerljive informacije o drogah in zasvojenosti z njimi ter o njihovih posledicah. — Zbiranje in analizi­ ranje podatkov.
Comprises one representative from each Member State, two represen­ tatives of the Commission and two independent experts designated by the European Parliament. 
Sestavljajo ga po en predstavnik vsake države članice, dva predstavnika Komisije in dva neodvisna strokov­ njaka, ki ju določi Evropski parlament. jona EUR).
Community subsidy 93 % (93 %). 
Subvencija Skup­ nosti 93 % (93 %).
The Centre runs a computerised network for the collection and exchange of information called the ‘European Information Network on Drugs and Drug Addiction’ (Reitox); this network connects national drug information networks, specialist centres in the Member States and the information systems of international organi­ sations working with the Centre. 
Center upravlja informacijsko omrežje za zbiranje in izmenjavo informacij, imenovano „Evropsko informacijsko omrežje za droge in zasvojenost z drogami“ (Reitox); to omrežje povezuje nacionalna informacijska omrežja za droge, specializirane centre v državah članicah in informacijske sisteme mednarodnih organi­ zacij, ki sodelujejo s Centrom.
1. monitoring the state of the drugs problem, and emerging trends, in particular those involving multi-drug use; Appointed by the Management Board at the Commission’s proposal. contracts, contract staff and temporary replacements) 2. monitoring the solutions and providing information on best practices; — To identify new developments and changing trends. 
1. spremljanje stanja na področju problema drog in nastajajočih trendov, predvsem tistih, ki zadevajo uporabo več drog; Imenuje ga upravni odbor na predlog Komisije.
3 — Scientific Committee — Selected issues 3 (3) issues, publication, multilingual summaries EN), 3. assessing the risks of new psychoactive substances and maintaining a rapid information system; Delivers opinions. 
Zasedena delovna mesta: 78 — letno poročilo o stanju problema drog v Evropi; 23 (23) jezikovnih različic, objava in interaktivna spletna stran, 2. spremljanje rešitev in zagota­ vljanje informacij o najboljših praksah; 3 – Znanstveni odbor (73) + 26 (25) drugih uslužbencev — objave izbranih številk – 3 (3), objavljanje, večjezični povzetki EN), 3. ocenjevanje tveganj pri novih psihoaktivnih substancah in vzdrževanje sistema hitre izmenjave informacij; — Opredelitev razvojnih novosti in spreminjajočih se trendov.
It consists of at most 15 well-known scientists appointed in view of their excellence by the Management Board following a call for expressions of interest. 
Sestavlja ga največ petnajst poznanih znanstvenikov, ki jih glede na njihovo odličnost imenuje upravni odbor po razpisu za prijavo interesa.
The Management Board may also appoint a panel of experts to the extended Scientific Committee for risk assessment of new psychoactive substances. Total staff: 104 (98) Assigned to the following — Statistical bulletin and interactive website containing over 350 (350) tables, 100 (100) graphs, 4. developing tools and instruments to help Member States to monitor and evaluate their national policies and the Commission to monitor and evaluate EU policies. administrative and IT support: 32 (29) (4), — Drugs in Focus (policy briefings) — 1 (3) — To improve data-comparison methods. 
Upravni odbor lahko v razšir­ jeni znanstveni odbor imenuje tudi skupino strokovnjakov za oceno tveganja pri novih psihoaktivnih substancah. (pomožni uslužbenci, pogodbeni uslužbenci in začasni uslužbenci) — statistični bilten in interaktivna spletna stran z več kot 350 (350) tabelami in 100 (100) diagrami, 4. razvijanje orodij in instru­ mentov za pomoč državam članicam pri spremljanju in vrednotenju njihovih nacio­ nalnih politik ter Komisiji pri spremljanju in vrednotenju politik EU.
It adopts the work programme, the general activities report and the budget. 
Odbor sprejme delovni program, splošno poročilo o dejavnostih in proračun.
Staff at 31 December 2008 — To cooperate with European and inter­ national bodies and organisations and with third countries. 
Število zaposlenih 31. decembra 2008 — Sodelovanje z evropskimi in mednarodnimi organi ter organi­ zacijami in s tretjimi državami.
Publications 2 — Director Posts occupied: 78 (73) + 26 (25) other staff (auxiliary — Annual report on the state of the drug problem in Europe; 23 (23) language versions, publication and interactive website, 4 — External audit mixed: 10 (9) Court of Auditors. — EMCDDA Scientific monograph — 1 (0), two volumes, EN, 5 — Discharge authority Table European Monitoring Centre for Drugs and Drug Addiction (Lisbon) Parliament acting on a recommen­ dation from the Council. — EMCDDA Insights — 3 (0), EN, duties: operational: 62 (60) — General report of activities — annual, EN, — Drugnet Europe newsletter — 4 issues, EN (Data for 2007) issue, 25 language versions, — EMCDDA technical datasheets — 3 (0), — Drug profiles — 5 new and 6 updated (6), DE, EN, FR, 
2 – Direktor Število delovnih mest v kadrovskem načrtu: 82 (82) Publikacije 4 – Zunanja revizija upravne in podpora IT: 32 — Drugs in Focus (obvestila o politiki) – 1 (3) številka, 25 jezikovnih različic, Računsko sodišče. 5 – Organ za razrešnico Parlament na priporočilo Sveta. (29) razne: 10 (9) — znanstvena monografija Centra – 1 (0), dva zvezka, EN, Tabela Evropski center za spremljanje drog in zasvojenosti z drogami (Lizbona) Skupno število zaposlenih: 104 (98) (podatki za leto 2007) — glasilo Drugnet Europe – 4 številke, EN (4), — EMCDDA Insights (tematski povzetki) – 3 (0), v angleščini, — tehnične specifikacije Centra – 3 (0), — profili drog – 5 novih in 6 posodobljenih (6), DE, EN, FR,
EN C 304/152 Official Journal of the European Union 15.12.2009 Areas of Community competence deriving from the Treaty The Centre’s powers as defined in Regulation (EC) No 1920/2006 of the European Parliament and of the Council of 12 December 2006 Governance Resources available to the Centre in 2008 (Data for 2007) Products and services supplied in 2008 Source: Information supplied by the Centre. — Technical and scientific studies, including articles and scientific summaries 53 (57), — Data collection, validation, storage and retrieval system (Fonte). 
SL C 304/152 Uradni list Evropske unije 15.12.2009 Področja pristojnosti Skupnosti, ki izhajajo iz Pogodbe Pristojnosti Centra, kot so opredeljene v Uredbi (ES) št. 1920/2006 Evropskega parlamenta in Sveta z dne 12. decembra 2006 Viri, ki so bili Centru na voljo v letu Proizvodi in storitve, zagotovljeni v letu 2008 Vir: Podatki, ki jih je posredoval Center. Vodenje 2008 (podatki za leto 2007) (podatki za leto 2007) — tehnične in znanstvene študije, vključno s članki in znanstvenimi povzetki 53 (57), — sistem za zbiranje, potrjevanje, shranjevanje in iskanje podatkov (Fonte).
Other websites (Data for 2007) Set-up/updating/content development of public EMCDDA website including: — country overviews, — drug treatment overviews, — european legal database on drugs, — evaluation instruments bank, — best practice portal (exchange on drug demand reduction action). Promotional brochures: 6 (3) products. 
Druge spletne strani Vzpostavitev/posodabljanje/razvoj vsebine na javni spletni strani Centra, vključno: — s povzetki o stanju po državah, — s pregledi zdravljenja zasvojenosti z drogami, — z evropsko pravno podatkovno zbirko o drogah, — z zbirko instrumentov za vrednotenje, — s portalom o najboljših praksah (izmenjava v zvezi z ukrepi za zmanjšanje povpraševanja po drogah).
Media products: 177 (174) miscellaneous products. Participation in international conferences/ meetings: 203 (230). Organisation of technical and scientific meetings: 35 (41). 
Promocijske brošure: 6 (3) izdelkov Medijski proizvodi: 177 (174) različnih izdelkov Sodelovanje na mednarodnih konferencah/ sestankih: 203 (230) Organizacija tehničnih in znanstvenih sestankov: 35 (41)
EN 15.12.2009 OfficialJournaloftheEuropeanUnion C304/153 THE CENTRE’S REPLIES 13. 
SL 15.12.2009 UradnilistEvropskeunije C304/153 ODGOVORI CENTRA 13.
In line with the Court’s recommendations, the EMCDDA’s 2009 work programme ensures a better link between priorities, objectives and activities to be implemented. 
V skladu s priporočili Sodišča je v delovnem programu EMCDDA za leto 2009 zagotovljena boljša povezava med prednostnimi področji, cilji in dejavnostmi, ki jih je treba izvesti.
It also allocates financial and human resources to the different priorities and activities on the basis of the estimated costs for implementation. 
Tudi finančni in kadrovski viri so dodeljeni različnim prednostnim področjem in dejavnostim na osnovi ocenjenih stroškov izvajanja.
Mid-term progress reporting was carried out to monitor the state of implementation. 
Za spremljanje stanja je bilo pripravljeno vmesno poročilo o napredku.
Moreover, for the 2010–2012 planning cycle the activity-based management (ABM) approach was improved by promoting result-oriented processes, establishing more measurable objectives and developing appropriate performance indicators. 
Poleg tega je bil za načrtovano obdobje 2010–2012 izboljšan pristop upravljanja na podlagi dejavnosti, in sicer s spodbujanjem postopkov, usmerjenih v rezultate, določanjem lažje merljivih ciljev in razvijanjem ustreznih kazalcev uspešnosti.
5.12.2008 EN Official Journal of the European Union C 311/27 REPORT on the annual accounts of the European Medicines Agency for the financial year 2007 together with the AgencyŐs replies (2008/C 311/05) CONTENTS INTRODUCTION ........................................................... STATEMENTOFASSURANCE ................................................. 
3–6 OPAŽANJA................................................................
Paragraph Page 28 28 28 30 33 1-2 3-6 
Odstavek Stran 28 28 28 30 33
C 311/28 EN Official Journal of the European Union 5.12.2008 INTRODUCTION 1. 
C 311/28 SL Uradni list Evropske unije 5.12.2008 UVOD 1.
The European Medicines Agency (hereinafter the Agency) was created by Council Regulation (EEC) No 2309/93 of 22 July 1993, which was replaced by Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 (1). 
Evropska agencija za zdravila (v nadaljnjem besedilu „Agencija“) je bila ustanovljena z Uredbo Sveta (EGS) št. 2309/93 z dne 22. julija 1993, ki jo je nadomestila Uredba (ES) št.
The Agency operates through a network and coordinates the scientific resources made available by the national authorities in order to ensure the evaluation and supervision of medicinal products for human or veterinary use. 
Agencija deluje prek mreže in usklajuje znanstvene vire, ki jih dajo na razpolago nacionalni organi, tako da zagotovi vrednotenje zdravil za humano in veterinarsko uporabo in nadzor nad njimi.
Key data summarised from the financial statements drawn up by the Agency for the financial year 2007 are presented inTables 2, 3 and 4for information purposes. 
Povzetek ključnih podatkov iz računovodskih izkazov, ki jih je Agencija pripravila za proračunsko leto 2007, je v informativne namene prikazan v tabelah 2, 3 in 4.
This Statement is addressed to the European Parliament and the Council in accordance with Article 185(2) of Council Regulation (EC, Euratom) No 1605/2002 (2); it was drawn up following an examination of the AgencyŐs accounts, as required by Article 248 of the Treaty establishing the European Community. 
Ta izjava je naslovljena na Evropski parlament in Svet v skladu s členom 185(2) Uredbe Sveta (ES, Euratom) št. 1605/2002 (2). Oblikovana je bila po pregledu računovodskih izkazov Agencije, kot določa člen 248 Pogodbe o ustanovitvi Evropske skupnosti.
The AgencyŐs accounts for the financial year ended 31 December 2007 (3) were drawn up by its Executive Director, pursuant to Article 68 of Regulation (EC) No 726/2004, and sent to the Court, which is required to give a Statement of Assurance on their reliability and on the legality and regularity of the underlying transactions. 
Računovodske izkaze Agencije za proračunsko leto, ki se je končalo 31. decembra 2007 (3), je v skladu s členom 68 Uredbe (ES) št. 726/2004 pripravil njen izvršni direktor, nato pa so bili poslani Sodišču, ki mora podati izjavo o njihovi zanesljivosti ter o zakonitosti in pravilnosti z njimi povezanih transakcij.
The Court conducted its audit in accordance with the IFAC and ISSAI (4) International Auditing Standards and Codes of Ethics, insofar as these are applicable in the European Community context. 
Sodišče je svojo revizijo opravilo v skladu z mednarodnimi standardi revidiranja in etičnima kodeksoma MZRS in ISSAI (4), v kolikor so ti uporabni v kontekstu Evropske skupnosti.
(1) OJ L 214, 24.8.1993, p. 
(1) UL L 214, 24.8.1993, str.
18 and OJ L 136, 30.4.2004, p. 
18 in UL L 136, 30.4.2004, str.
Pursuant to the latter Regulation the AgencyŐs original name, the European Agency for the Evaluation of Medicinal Products, was changed to the European Medicines Agency. 
V skladu s slednjo Uredbo je bil prvotni naziv Agencije Evropska agencija za vrednotenje zdravil spremenjen v naziv Evropska agencija za zdravila.
(3) These accounts were drawn up on 15 June 2008 and received by the Court on 1 July 2008. 
(3) Ti računovodski izkazi so bili pripravljeni 15. junija 2008, Sodišče pa jih je prejelo 1. julija 2008.
The AgencyŐs final budget for 2007 amounted to 163,1 million euro as compared with 138,7 million euro the previous year. 
Končni proračun Agencije za leto 2007 je znašal 163,1 milijona EUR v primerjavi s 138,7 milijona EUR v prejšnjem letu.
Of the budget appropriations, 32 million euro were carried over and 4 million euro were cancelled. 
Prenesenih je bilo 32 milijonov EUR odobrenih proračunskih sredstev, 4 milijoni EUR pa so bili razveljavljeni.
As in 2006, the high level of carry-overs for administrative expenditure, 18,9 million euro, was mainly due to the programme Telematics for the regulation of medical products. 
Tako kot v letu 2006 je prišlo do visoke stopnje prenosov za administrativne odhodke v višini 18,9 milijona EUR predvsem zaradi telematskega programa EU za ureditev zdravil.
The Agency and the other parties involved in this programme must ensure better planning and monitoring of the implementation of the programme. 
Agencija in druge strani, udeležene v tem programu, morajo zagotoviti boljše načrtovanje in spremljanje izvajanja programa.
The Agency should consider using the differentiated appropriations system for the Telematics programme which is more suitable for the budgetary management of such programmes. 
Agencija mora razmisliti o uporabi sistema diferenciranih sredstev za telematski program, saj je takšen sistem primernejši za upravljanje proračuna takšnih programov.
The audit of the tendering procedures showed weaknesses: insufficient justification of the chosen procedures (5) and inadequate evaluation methods for the price criteria (6). 
Revizija razpisnih postopkov je pokazala na slabosti: nezadostna utemeljitev izbranih postopkov (5) in neustrezne metode vrednotenja za cenovna merila (6).
In the case of a joint public procurement procedure with five other Agencies, the volume of the services to be procured had not been adequately identified. 
V primeru postopka skupnih javnih naročil s petimi drugimi agencijami ni bila ustrezno opredeljena količina naročenih storitev.
This resulted in difficulties in evaluating the cost of the bids as well as the need to review the volumes and values of the services to be procured. 
Zaradi tega so nastale težave pri vrednotenju stroška ponudb in potreba po pregledu količin in vrednosti naročenih storitev.
The Agency should aim to improve the quality of its public procurement procedures in order to address the issues highlighted above. 
Agencija si mora prizadevati za izboljšanje kakovosti svojih postopkov javnega naročanja, da se rešijo zgoraj opisana vprašanja.
(5) Two cases. 
(5) Dva primera.
(6) Three cases. 
(6) Trije primeri.
5.12.2008 EN Official Journal of the European Union C 311/29 9. 
5.12.2008 SL Uradni list Evropske unije C 311/29 9.
In its 2006 report (1), the Court observed that the Agency had not performed a comprehensive analysis of the costs incurred by rapporteurs. 
Sodišče je v svojem poročilu za leto 2006 (1) ugotovilo, da Agencija ni izvedla izčrpne analize stroškov, nastalih pri poročevalcih.
The Management Board of the Agency has established a Costing Group which at the end of 2007 prepared a report on a generally accepted international costing methods and a proposal for an alternative option for remunerating the rapporteurs. 
Uprava Agencije je ustanovila stroškovno skupino, ki je ob koncu leta 2007 pripravila poročilo o splošno sprejetih mednarodnih stroškovnih metodah in predlog za alternativno možnost plačevanja nadomestil poročevalcem.
The Court welcomes the steps the Agency has made in order to address the issue of the evaluation of the costs and calls for further progress. 
Sodišče pozdravlja ukrepe, ki jih je Agencija uvedla za reševanje vprašanja vrednotenja stroškov, in poziva k nadaljnjemu napredku.
For the Court of Auditors Vtor Manuel da SILVA CALDEIRA President (1) OJ C 309, 19.12.2007, p. 
Za Računsko sodišče Vítor Manuel da SILVA CALDEIRA Predsednik (1) UL C 309, 19.12.2007, str.
C 311/30 EN Official Journal of the European Union 5.12.2008 Areas of Community competence deriving from the Treaty Competences of the Agency as defined in Regulation (EC) No 726/2004 of the European Parliament and of the Council Governance 1. 
C 311/30 SL Uradni list Evropske unije 5.12.2008 Področja pristojnosti Skupnosti, ki izhajajo iz Pogodbe Pristojnosti Agencije, kot jih opredeljuje Uredba (ES) št.
The Committee for Medicinal Products for Resources made available to the Agency in 2007 (Data for 2006) Products and Services in 2007 A high level of human health protection shall be ensured in the definition and implementation of all Community policies and activities. 
726/2004 Evropskega parlamenta in Sveta Vodenje Viri, ki so bili Agenciji na voljo v letu 2007 (Podatki za leto 2006) Proizvodi in storitve v letu 2007 Pri opredeljevanju in izvajanju vseh politik in dejavnosti Skupnosti se zagotavlja visoka raven varovanja zdravja ljudi.
Objectives Tasks Final budget for 2007: Medicinal Products for Human Use Community action, which shall complement national policies, shall be directed towards improving public health, preventing human illness and diseases and obviating sources of danger to human health. (...) of medicinal products for human and veterinary use. 
Cilji Naloge 1. stavljen iz enega člana ter enega namestnika iz vsake države članice, svetuje o vseh vprašanjih, povezanih z vrednotenjem zdravil za uporabo v humani medicini. Dejavnost Skupnosti, ki dopolnjuje nacionalne politike, je usmerjena k izboljševanju javnega zdravja, preprečevanju človekovih obolenj in bolezni ter odpravljanju vzrokov, ki ogrožajo zdravje ljudi. (...)
The Committee for Medicinal Products for Veterinary Use, consisting of one member and one alternate from each MemberState, advises on any question relating to the evaluation of veterinary medicinal products. 
Odbor za zdravila za veterinarsko uporabo, ki je sestavljen iz enega člana ter enega namestnika iz vsake države članice, svetuje o vseh vprašanjih, povezanih z vrednotenjem zdravil za uporabo v veterinarski medicini.